Fox Jocelyn E Manning, Magga Jarkko, Giles Wayne R, Light Peter E
Department of Pharmalology, University of Alberta, Edmonton, Alberta, Canada.
Metabolism. 2003 Oct;52(10):1313-9. doi: 10.1016/s0026-0495(03)00199-9.
Recent evidence demonstrates that long-chain acyl coenzyme A esters (CoAs) activate cardiac and beta-cell plasma-membrane (pmK(ATP)) adenosine triphosphate (ATP)-sensitive potassium channels. In this study, we have investigated the differential effects of acyl CoAs of short and medium side-chain length on cardiac and beta-cell pmK(ATP) isoforms. At the single-channel level, the addition of acyl CoAs of differing side-chain length (2 to 16 carbons) to the inside face of membrane patches from ventricular myocytes caused varying increases in pmK(ATP) channel open probability proportional to increases in acyl side-chain length (20 mumol/L acetyl CoA: 310% +/- 90%, 20 mumol/L decanoyl CoA: 570% +/- 150%). A similar dependence of activation on side-chain length was observed in recombinant pmK(ATP) channels (SUR2A/Kir6.2) with full activation of current requiring both the acyl and CoA moieties in the esterified form. We found the recombinant beta-cell K(ATP) channel (SUR1/Kir6.2) to be much less sensitive to medium-chain acyl CoAs (decanoyl CoA: 124% +/- 15% v 231% +/- 25% in SUR2A/Kir6.2), suggesting a role for the cardiac sulfonylurea receptor, SUR2A, in the molecular mechanism of activation by these compounds. We propose that fatty acid metabolism, and the resultant generation of acyl CoAs of varying side-chain length, may be an important regulator of cellular excitability via interactions with the K(ATP) channel.
最近的证据表明,长链酰基辅酶A酯(CoAs)可激活心肌和β细胞膜(pmK(ATP))上的三磷酸腺苷(ATP)敏感性钾通道。在本研究中,我们调查了短链和中链长度的酰基辅酶A对心肌和β细胞pmK(ATP)亚型的不同影响。在单通道水平上,将不同侧链长度(2至16个碳)的酰基辅酶A添加到心室肌细胞膜片的内表面,会导致pmK(ATP)通道开放概率不同程度增加,且与酰基侧链长度的增加成正比(20 μmol/L乙酰辅酶A:310%±90%,20 μmol/L癸酰辅酶A:570%±150%)。在重组pmK(ATP)通道(SUR2A/Kir6.2)中也观察到激活对侧链长度有类似的依赖性,电流的完全激活需要酯化形式的酰基和辅酶A部分。我们发现重组β细胞K(ATP)通道(SUR1/Kir6.2)对中链酰基辅酶A的敏感性要低得多(癸酰辅酶A:124%±15%,而SUR2A/Kir6.2中为231%±25%),这表明心脏磺脲类受体SUR2A在这些化合物激活的分子机制中起作用。我们提出,脂肪酸代谢以及由此产生的不同侧链长度的酰基辅酶A,可能通过与K(ATP)通道相互作用,成为细胞兴奋性的重要调节因子。